374 results on '"Trovato, Francesca"'
Search Results
2. Liver Elastography in Acute Liver Failure: A Pilot Study
3. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure
4. FRI-335 An exploration of plasma neurofilament protein as a marker of neuronal damage in acute liver failure
5. WED-075-YI Exploring the immunomodulatory potential of TLR7/8 agonism in decompensated cirrhosis
6. Immunometabolic analysis shows a distinct cyto-metabotype in Covid-19 compared to sepsis from other causes
7. Macrophage activation markers are associated with infection and mortality in patients with acute liver failure.
8. Autotaxin upregulation in liver failure and the effect on monocyte phenotype and function is a pan-aetiology phenomenon.
9. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
10. Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints
11. Microcirculatory, Endothelial and Inflammatory Responses in Critically Ill Patients with COVID-19 are Distinct from those Seen in Septic Shock: A Case Control Study
12. Fetal Programming: Maternal Diets, Tryptophan, and Postnatal Development
13. Physical activity and Mediterranean diet based on olive tree phenolic compounds from two different geographical areas have protective effects on early osteoarthritis, muscle atrophy and hepatic steatosis
14. Reply to: “Dysregulation of the LPC-ATX-LPA axis in autoimmune hepatitis is associated with monocyte activation”: Autotaxin upregulation in liver failure and the effect on monocyte phenotype and function is a pan-aetiology phenomenon
15. Osteopontin serves as a potential regulator of T cell immunity in patients with hepatocellular carcinoma
16. Soluble and monocyte surface CD206 is a promising indicator of sepsis in patients with acute liver failure
17. Echocardiography and NAFLD (non-alcoholic fatty liver disease)
18. Potential therapies for acute‐on‐chronic liver failure
19. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study
20. PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury
21. Update on the management of acute liver failure
22. Liver and spleen transient elastography and Acoustic Radiation Force Impulse Measurements. Performance and comparison of measurements in the same area concurrently assessed for liver fibrosis by biopsy
23. Mediterranean diet and non-alcoholic fatty liver disease: The need of extended and comprehensive interventions
24. HPB P08 Exploring Carbon-13 breath delta value and other biomarkers of infection following Liver Transplantation and Hepatopancreatobiliary Surgery
25. P39 Systemic inflammation associated microRNA as novel biomarkers for clinical decompensation in patients with cirrhosis
26. Proximity labelling reveals potential cis interactions of CD52 glycoprotein counter-receptors on circulating CD4+HLA-G+ regulatory T cells in acute decompensation of cirrhosis
27. Untargeted lipidomics unveils a specific plasma signature of severe alcoholic hepatitis
28. High plasma level of osteopontin, a potential biomarker in hepatocellular carcinoma, is associated with weakened anti-tumour immunity
29. Untargeted lipidomics differentiate ACLF precipitated by severe alcoholic hepatitis
30. The prognostic role of lysophosphatidylcholines and their immunomodulatory potential in acute liver failure
31. miRNA associated with systemic inflammation may have prognostic utility in predicting decompensation in patients with chronic liver disease
32. Shear wave elastography is a useful and accurate tool to triage patients with acute liver failure syndromes
33. Addressing Western dietary pattern in obesity and NAFLD
34. EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015
35. Contrast-enhanced ultrasound does not discriminate between community acquired pneumonia and lung cancer
36. Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
37. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics
38. Association of cardiometabolic microRNAs with COVID-19 severity and mortality
39. Effects of high-tryptophan diet on pre- and postnatal development in rats: a morphological study
40. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion
41. miRNA associated with systemic inflammation may have prognostic utility in predicting decompensation in patients with chronic liver disease
42. Coffee Consumption and Neglected Risk-Benefits on Health and Disease
43. Coffee and Prevention of Nonalcoholic Fatty Liver Disease
44. Coffee and Renal Function and Disease
45. Thoracic Ultrasound Limitations in the Differential Diagnosis of Respiratory Failure Causes
46. Suppressor CD4+T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis
47. Advantages of Thoracic Ultrasound-Guided Fine-Needle Aspiration Biopsy in Lung Cancer and Mesothelioma
48. The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis
49. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation
50. Adenovirus-36 Seropositivity Enhances Effects of Nutritional Intervention on Obesity, Bright Liver, and Insulin Resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.